Inventor · disambiguated record
Sheena K. Aurora
Also filed as: AURORA SHEENA · AURORA SHEENA K · AURORA SHEENA KAUR
9 granted patents·4 pending applications·130 citations·filing 2005–2023
90Inventor score
Top patents by PatentIndex Score
13 records- 0196US8936790B2Injection paradigm for administration of botulinum toxinsALLERGAN INC·Filed 2013·Granted Jan 20, 2015·31 cites·8 claims
- 0295US8968747B2Injection paradigm for administration of botulinum toxinsALLERGAN INC·Filed 2013·Granted Mar 3, 2015·22 cites·8 claims
- 0395US8501195B2Injection paradigm for administration of botulinum toxinsTURKEL CATHERINE C·Filed 2011·Granted Aug 6, 2013·45 cites·5 claims
- 0492US11033610B2Injection paradigm for administration of botulinum toxinsALLERGAN INC·Filed 2019·Granted Jun 15, 2021·2 cites·18 claims
- 0592US9279001B2Injection paradigm for administration of botulinum toxinsALLERGAN INC·Filed 2013·Granted Mar 8, 2016·11 cites·9 claims
- 0691US10406213B2Injection paradigm for administration of botulinum toxinsALLERGAN INC·Filed 2017·Granted Sep 10, 2019·6 cites·12 claims
- 0791US2024342256A1Injection paradigm for administration of botulinum toxinsALLERGAN INC·Filed 2023·Application pending·0 cites
- 0890US9764011B2Injection paradigm for administration of botulinum toxinsALLERGAN INC·Filed 2016·Granted Sep 19, 2017·5 cites·20 claims
- 0989US7910116B2Use of a botulinum toxin to improve gastric emptying and/or to treat GERDALLERGAN INC·Filed 2005·Granted Mar 22, 2011·8 cites·12 claims
- 1077US11819541B2Injection paradigm for administration of botulinum toxinsALLERGAN INC·Filed 2021·Granted Nov 21, 2023·0 cites·19 claims
- 1149US2021340230A1Anti-CGRP Antibodies For Treatment-Resistant PatientsLILLY CO ELI·Filed 2019·Application pending·0 cites
- 1244US2020268735A1Combination Therapy of Lasmiditan and a CGRP Antagonist for Use in the Treatment of MigraineLILLY CO ELI·Filed 2018·Application pending·0 cites
- 1332US2011117070A1Compositions and methods for treating headacheAURORA SHEENA K·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →